Activation of the glucagon receptor increases energy expenditure and may help reduce liver fat
Ongoing clinical success, regulatory submissions, and backing by Eli Lilly further drive rapid market growth, making Orforglipron a leading therapy in both obesity management and type 2 diabetes treatment
"This incidence was significantly higher compared to patients not on a GLP-1 RA, showing a strong link between GLP-1 RA drugs and potential aspiration risk under anaesthesia." The study was prompted by internal quality reviews led by Nwokolo and associate professor in the department, Dr Srikanth Sridhar, after anecdotal cases of aspiration under anaesthesia were reported by staff for patients taking this class of medications for weight loss, despite adequate fasting before the procedure
Weight Loss in Obese Adults In a 48-week phase 2 trial published in The New England Journal of Medicine , retatrutide demonstrated unprecedented weight loss efficacy in adults with obesity
GLP-1s can directly improve heart health by activating endothelial cells, which allows blood vessels to relax and widen